| Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study C Langkammer, F Schweser, N Krebs, A Deistung, W Goessler, ... Neuroimage 62 (3), 1593-1599, 2012 | 982 | 2012 |
| Quantitative MR imaging of brain iron: a postmortem validation study C Langkammer, N Krebs, W Goessler, E Scheurer, F Ebner, K Yen, ... Radiology 257 (2), 455-462, 2010 | 633 | 2010 |
| Serum neurofilament light levels in normal aging and their association with morphologic brain changes M Khalil, L Pirpamer, E Hofer, MM Voortman, C Barro, D Leppert, ... Nature communications 11 (1), 812, 2020 | 606 | 2020 |
| Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects C Enzinger, F Fazekas, PM Matthews, S Ropele, H Schmidt, S Smith, ... Neurology 64 (10), 1704-1711, 2005 | 555 | 2005 |
| White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study R Schmidt, S Ropele, C Enzinger, K Petrovic, S Smith, H Schmidt, ... Annals of Neurology: Official Journal of the American Neurological …, 2005 | 487 | 2005 |
| Brain atrophy and lesion load predict long term disability in multiple sclerosis V Popescu, F Agosta, HE Hulst, IC Sluimer, DL Knol, MP Sormani, ... Journal of Neurology, Neurosurgery & Psychiatry 84 (10), 1082-1091, 2013 | 441 | 2013 |
| A novel imaging marker for small vessel disease based on skeletonization of white matter tracts and diffusion histograms E Baykara, B Gesierich, R Adam, AM Tuladhar, JM Biesbroek, HL Koek, ... Annals of neurology 80 (4), 581-592, 2016 | 429 | 2016 |
| Heterogeneity in age-related white matter changes R Schmidt, H Schmidt, J Haybaeck, M Loitfelder, S Weis, M Cavalieri, ... Acta neuropathologica 122 (2), 171-185, 2011 | 422 | 2011 |
| Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study R Schmidt, C Enzinger, S Ropele, H Schmidt, F Fazekas The Lancet 361 (9374), 2046-2048, 2003 | 397 | 2003 |
| Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial P Novak, R Schmidt, E Kontsekova, N Zilka, B Kovacech, R Skrabana, ... The Lancet Neurology 16 (2), 123-134, 2017 | 367 | 2017 |
| Quantitative susceptibility mapping in multiple sclerosis C Langkammer, T Liu, M Khalil, C Enzinger, M Jehna, S Fuchs, F Fazekas, ... Radiology 267 (2), 551-559, 2013 | 364 | 2013 |
| Novel genetic loci associated with hippocampal volume DP Hibar, HHH Adams, N Jahanshad, G Chauhan, JL Stein, E Hofer, ... Nature communications 8 (1), 13624, 2017 | 356 | 2017 |
| Differential developmental trajectories of magnetic susceptibility in human brain gray and white matter over the lifespan W Li, B Wu, A Batrachenko, V Bancroft‐Wu, RA Morey, V Shashi, ... Human brain mapping 35 (6), 2698-2713, 2014 | 327 | 2014 |
| Acute cerebrovascular disease in the young: the Stroke in Young Fabry Patients study A Rolfs, F Fazekas, U Grittner, M Dichgans, P Martus, M Holzhausen, ... Stroke 44 (2), 340-349, 2013 | 315 | 2013 |
| Quantitative susceptibility mapping in Parkinson's disease C Langkammer, L Pirpamer, S Seiler, A Deistung, F Schweser, S Franthal, ... PLoS One 11 (9), e0162460, 2016 | 285 | 2016 |
| Fast quantitative susceptibility mapping using 3D EPI and total generalized variation C Langkammer, K Bredies, BA Poser, M Barth, G Reishofer, AP Fan, ... Neuroimage 111, 622-630, 2015 | 284 | 2015 |
| Progression of leukoaraiosis and cognition R Schmidt, K Petrovic, S Ropele, C Enzinger, F Fazekas Stroke 38 (9), 2619-2625, 2007 | 283 | 2007 |
| Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis C Granziera, J Wuerfel, F Barkhof, M Calabrese, N De Stefano, ... Brain 144 (5), 1296-1311, 2021 | 266 | 2021 |
| Quantifying blood-brain barrier leakage in small vessel disease: review and consensus recommendations MJ Thrippleton, WH Backes, S Sourbron, M Ingrisch, MJP van Osch, ... Alzheimer's & Dementia 15 (6), 840-858, 2019 | 260 | 2019 |
| Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study H Jokinen, J Lipsanen, R Schmidt, F Fazekas, AA Gouw, ... Neurology 78 (22), 1785-1792, 2012 | 229 | 2012 |
Christian LangkammerDepartment of Neurology, Medical University of Graz, AustriaVerified email at neuroimaging.at
